TCRx is the company which is working on the development of T-cell based cancer therapy. Its focus is on immunology — it manipulates the TCR molecular on T-cells to generate modified T-cell to treat cancer. TCR molecule study is the key for the company.

In other words, the company produces modified patient T-cells to kill a patient’s tumor.
The therapy is personalized and a patient gets several TCR DNA sequences as prescription.

The next slide shows the idea of the logo and how it appeared from a complex brief provided by the client.